Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial.

Pavel M, Hörsch D, Caplin M, Ramage J, Seufferlein T, Valle J, Banks P, Lapuerta P, Sands A, Zambrowicz B, Fleming D, Wiedenmann B.  Journal of Clinical Endocrinology and Metabolism, 2015; 100: 1511-9.

Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumors.

Valle JW, Faivre S, Hubner RA, Grande E, Raymond E. Cancer Treatment  Reviews, 2014; 40: 1230-8.

Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality.

Dobson R, Burgess MI, Valle JW, Pritchard DM, Vora J, Wong C, Chadwick C, Keevi B, Adaway J, Hofmann U, Poston GJ, Cuthbertson DJ. British Journal of Cancer, 2014; 111: 1703-9.

Risk-reducing laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasm: early outcomes and technique.

Fish R, Selvasekar C, Crichton P, Wilson M, Fulford P, Renehan A, O'Dwyer S. Surgical Endoscopy, 2014; 28: 341-5.

Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours.

Meyer T, Qian W, Caplin ME, Armstrong G, Lao-Sirieix SH, Hardy R, Valle JW, Talbot DC, Cunningham D, Reed N, Shaw A, Navalkissoor S, Luong TV, Corrie PG. European Journal of Cancer, 2014; 50 :902-11. 

A systematic review of non-surgical treatments for pancreatic neuroendocrine tumours.

Valle JW, Eatock M, Clueit B, Gabriel Z, Ferdinand R, Mitchell S. Cancer Treatment Reviews, 2014; 40: 376-89.

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, Corrie P, Davar J, Davies AH, Lewington V, Meyer T, Newell-Price J, Poston G, Reed N, Rockall A, Steward W, Thakker RV, Toubanakis C, Valle J, Verbeke C, Grossman AB; UK and Ireland Neuroendocrine Tumour Society. Gut, 2012; 61: 6-32.

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A, Chen JS, Hörsch D, Hammel P, Wiedenmann B, Van Cutsem E, Patyna S, Lu DR, Blanckmeister C, Chao R, Ruszniewski P. New England Journal of Medicine, 2011; 364: 501-13.

A 3 year retrospective audit of chromogranin results in a tertiary referral centre: Is Chromogranin B measurement necessary?

Monaghan PJ, Darby D, Valle J, Mansoor W, Trainer PJ. Regulatory Peptides, 2010; 164: 12.

Last updated: August 2019